Levofloxacin Dosing for 3-Year-Old with Haemophilus influenzae
For a 3-year-old child weighing 14.7 kg with Haemophilus influenzae infection, give levofloxacin 147 mg (10 mg/kg) every 12 hours, not to exceed 250 mg per dose.
Dosing Rationale
The dosing for this child is based on age-specific pharmacokinetic differences that are critical to understand:
Age-Based Dosing Requirements
Children under 5 years of age clear levofloxacin approximately twice as fast as adults, resulting in significantly lower drug exposure 1. This faster clearance necessitates twice-daily dosing rather than once-daily dosing used in older children and adults 2.
The FDA-approved pediatric dosing is:
- Children 6 months to 5 years: 16-20 mg/kg/day divided every 12 hours (8-10 mg/kg per dose) 2
- Children >5 years: 10 mg/kg once daily 2
- Maximum single dose: 250 mg 1
Specific Calculation for This Patient
For your 14.7 kg patient:
- 10 mg/kg × 14.7 kg = 147 mg per dose
- Give every 12 hours (total daily dose: 294 mg/day)
- This dose is well below the 250 mg maximum per dose
Clinical Context
Levofloxacin is appropriate for Haemophilus influenzae infections when other agents are unsuitable 2. The guideline specifically lists levofloxacin as effective therapy for H. influenzae in acute otitis media, sinusitis, and pneumonia 2.
Important Caveats
Musculoskeletal risks: Fluoroquinolones cause arthropathy in pediatric patients. In surveillance studies, levofloxacin-treated children had higher rates of musculoskeletal disorders (primarily arthralgia) compared to non-fluoroquinolone-treated children, though most cases were mild and resolved without sequelae 1. Reserve levofloxacin for situations where benefits outweigh these risks.
Formulation considerations: The 100 mg dispersible tablet formulation would be most practical for achieving the 147 mg dose (1.5 tablets). If using 250 mg tablets, you cannot achieve precise dosing for this weight.
Duration of Therapy
Typical duration is 10 days for respiratory tract infections caused by H. influenzae 2, though this should be adjusted based on clinical response and infection severity.